Cara Therapeutics, Inc. (TVRD) SEC Filings — 2024

Filings

• Cara Therapeutics Files 8-K — 8-K · Dec 30, 2024
• Cara Therapeutics Files 8-K/A Amendment — 8-K/A · Dec 20, 2024
• PolyPid to Acquire Cara Therapeutics for $375M — 8-K · Dec 18, 2024
• Cara Therapeutics Faces Delisting Concerns — 8-K · Nov 22, 2024
• Cara Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
• Vifor (International) Ltd. Discloses Stake in Cara Therapeutics — SC 13D · Oct 30, 2024
• Cara Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
• Cara Therapeutics Faces Delisting Concerns — 8-K · Aug 1, 2024
• Cara Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Jul 8, 2024
• Cara Therapeutics Reports Exit/Disposal Costs — 8-K · Jun 18, 2024
• Cara Therapeutics Files 8-K — 8-K · Jun 12, 2024
• Cara Therapeutics Files 8-K on Shareholder Votes and Financials — 8-K · Jun 7, 2024
• Cara Therapeutics Files 8-K for Financials — 8-K · May 13, 2024
• Cara Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
• Cara Therapeutics Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 22, 2024
• Cara Therapeutics Announces Executive Changes — 8-K · Mar 22, 2024
• Cara Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 6, 2024
• Cara Therapeutics Files 8-K on Financials — 8-K · Mar 4, 2024
• Cara Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Cara Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Cara Therapeutics Changes Business Address to 400 Atlantic St, Stamford — 8-K · Feb 2, 2024
• BlackRock Amends Cara Therapeutics Stake (13G/A) — SC 13G/A · Jan 29, 2024
• Cara Therapeutics 8-K: Exit/Disposal Activities, Reg FD Disclosure — 8-K · Jan 22, 2024